Synthesis and biological evaluation of N9-substituted harmine derivatives as potential anticancer agents
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Bioorganic & medicinal chemistry letters - 26(2016), 16, Seite 4015-4019 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Du, Hongtao [VerfasserIn] |
---|
Links: |
---|
RVK: |
---|
doi: |
10.1016/j.bmcl.2016.06.087 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1980575371 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1980575371 | ||
003 | DE-627 | ||
005 | 20230714205609.0 | ||
007 | tu | ||
008 | 160816s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bmcl.2016.06.087 |2 doi | |
028 | 5 | 2 | |a PQ20161201 |
035 | |a (DE-627)OLC1980575371 | ||
035 | |a (DE-599)GBVOLC1980575371 | ||
035 | |a (PRQ)c678-b79cbca7977c3d4fb35f1c662939278e84926ac5f327d631c5b0a2f43a6487a00 | ||
035 | |a (KEY)0209141020160000026001604015synthesisandbiologicalevaluationofn9substitutedhar | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |a 610 |q DE-600 |
084 | |a PHARM |2 fid | ||
084 | |a VA 2620 |q AVZ |2 rvk | ||
100 | 1 | |a Du, Hongtao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis and biological evaluation of N9-substituted harmine derivatives as potential anticancer agents |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Tian, Shan |4 oth | |
700 | 1 | |a Chen, Juncheng |4 oth | |
700 | 1 | |a Gu, Hongling |4 oth | |
700 | 1 | |a Li, Na |4 oth | |
700 | 1 | |a Wang, Junru |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier, 1991 |g 26(2016), 16, Seite 4015-4019 |w (DE-627)130952400 |w (DE-600)1063195-1 |w (DE-576)025097946 |x 0960-894X |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2016 |g number:16 |g pages:4015-4019 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.bmcl.2016.06.087 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_4305 | ||
936 | r | v | |a VA 2620 |
951 | |a AR | ||
952 | |d 26 |j 2016 |e 16 |h 4015-4019 |